Revance Therapeutics, Inc - Bathi resik saben saham sajrone patang kuartal pungkasan RVNC

Logo perusahaan publik Revance Therapeutics Inc (RVNC)

Revance Therapeutics (RVNC) dominates the aesthetics market through Daxxify, whose prolonged effect enables the company to maintain premium pricing. The current EPS YoY TTM growth rate clearly demonstrates profit dynamics, where the -27.00 level captures the latest values. Stable cash flow is driven by clinic loyalty to neuroproteins, while operational processes are strictly governed by FDA regulations on biomaterial disposal.

RVNC: Bathi saben saham sajrone rolas wulan pungkasan revance.com 11.02.2024 - 20.02.2024

Rincian metrik keuangan lan pasar Revance Therapeutics (RVNC)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental perusahaan:RVNC - Revance Therapeutics Inc.
Barang utama Revance Therapeutics Inc

Revance Therapeutics (RVNC) is investing in laboratory energy efficiency to comply with environmental standards. Such capital expenditures directly impact the profit calculation model, as reflected in the EPS TTM YoY growth rate. This metric measures the percentage change in adjusted net income over twelve months compared to the previous year. It allows for an assessment of the actual efficiency of business scaling. Analyzing this chart helps determine the asset's overheating stage.